#United States #New York #Inc. #Securities Fraud #Levi Korsinsky #Zynex

Class Action Lawsuit Against Zynex, Inc.

In a significant legal move, investors of Zynex, Inc. (NASDAQ: ZYXI) have initiated a class action lawsuit through the law firm Levi & Korsinsky, LLP. This action is intended to seek compensation for those who suffered losses due to purported securities fraud affecting the company over a defined period.

About the Case

The lawsuit pertains to allegations that Zynex, Inc. engaged in fraudulent practices related to its financial reporting. Investors who purchased Zynex stock from March 13, 2023, to March 11, 2025, may be eligible to recover their losses. Specifically, the complaint outlines that the defendants allegedly:

1. Exceeded Product Shipments: Zynex purportedly shipped medical products, including electrodes, in quantities that surpassed actual demand. This practice led to inflated revenue figures, misleading investors and the market.
2. False Claims: It is further alleged that these inflated figures drew scrutiny from various insurers, notably the U.S. military health insurance program, Tricare. This attention raised concerns about the legitimacy of the company's claims and practices.
3. Potential Adverse Consequences: Due to these practices, it was likely that the company would face serious repercussions, including potential removal from insurer networks and penalties from regulatory authorities.
4. Misleading Statements: As a result, the positive statements made by the defendants regarding Zynex's business operations and prospects were considered materially misleading, lacking a legitimate basis.

What’s Next for Investors?

For investors who have experienced financial losses due to these alleged practices, the law firm has provided a window until May 19, 2025, to file for lead plaintiff status in the lawsuit. It's important to note that participating in this class action does not require being a lead plaintiff to benefit from any potential recovery.

Legal Representation and No Costs Incurred

Levi & Korsinsky assures prospective class members that they can claim compensation without any upfront costs or obligations. Their extensive experience in securities litigation has notably garnered substantial returns for investors in similar situations, allowing them to establish a reputable track record in handling complex cases.

The law firm has more than 70 employees focused on serving investor-client needs and is recognized as one of the leading securities litigation firms in the United States, consistently featuring in ISS Securities Class Action Services' Top 50 Report.

Contact for Further Information

Investors seeking more information about the class action or who wish to participate can reach out directly to Levi & Korsinsky, LLP. Interested parties can contact:

• - Joseph E. Levi, Esq.
• - Phone: (212) 363-7500
• - Email: [email protected]

The firm has established its headquarters at 33 Whitehall Street, 17th Floor, New York, NY 10004.

This class action lawsuit against Zynex, Inc. underscores a critical reminder for investors to stay informed about the practices and declarations of companies in which they invest. The potential ramifications of misrepresented business statistics can be significant and may lead to legal repercussions, ultimately affecting shareholder investments across the board.

Investors are encouraged to remain vigilant and proactive in safeguarding their investments, particularly when it comes to understanding the implications of such legal cases. As this situation continues to unfold, updates from Levi & Korsinsky will shed more light on the progress and outcome of the lawsuit.